Kerydin is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Pharmaderm, A Division Of Fougera Pharmaceuticals Inc.. The primary component is Tavaborole.
Product ID | 10337-905_3d362b47-37c4-489d-91c6-a2b7ec99e207 |
NDC | 10337-905 |
Product Type | Human Prescription Drug |
Proprietary Name | Kerydin |
Generic Name | Tavaborole |
Dosage Form | Solution |
Route of Administration | TOPICAL |
Marketing Start Date | 2014-07-07 |
Marketing Category | NDA / NDA |
Application Number | NDA204427 |
Labeler Name | PharmaDerm, A division of Fougera Pharmaceuticals Inc. |
Substance Name | TAVABOROLE |
Active Ingredient Strength | 44 mg/mL |
Pharm Classes | Oxaborole Antifungal [EPC],Protein Synthesis Inhibitors [MoA],Boron Compounds [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2014-07-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204427 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-07-07 |
Marketing Category | NDA |
Application Number | NDA204427 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-07-07 |
Ingredient | Strength |
---|---|
TAVABOROLE | 43.5 mg/mL |
SPL SET ID: | 1ae61072-bca0-43f0-a741-07bda2d50c87 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
10337-905 | Kerydin | Tavaborole |
0574-0157 | Tavaborole | Tavaborole |
51672-1397 | TAVABOROLE | TAVABOROLE |
51862-690 | tavaborole | tavaborole |
62332-467 | Tavaborole | Tavaborole |
63629-8704 | Tavaborole | Tavaborole |
68180-958 | Tavaborole | Tavaborole |
69097-686 | TAVABOROLE | TAVABOROLE |
69238-1657 | Tavaborole | Tavaborole |
71589-010 | TAVABOROLE | TAVABOROLE |
72763-201 | Tavaborole | Tavaborole |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KERYDIN 86281630 4796355 Live/Registered |
Anacor Pharmaceuticals, Inc. 2014-05-14 |
KERYDIN 85672220 4653277 Live/Registered |
Anacor Pharmaceuticals, Inc. 2012-07-09 |